did tirzepatide get discontinued Causes and consequences of discontinuation of GLP1RAs or Friendly Reminder 💡 The only

GLP-1 receptor agonists GLP-1 receptor agonists and related incretin-based therapies have rapidly changed the treatment landscape for obesity, diabetes, and metabolic disease

Spoiler alert: the pros are really good

People who binge eat and people with a higher BMI are more likely to show certain impulsive behaviours.[3] And people taking GLP-1 drugs report less impulsive and compulsive shopping.[4] In this interview, Dr Guen Bradbury talks with Dr Eve McMahon about how medicine has been surprised by the increase in use of GLP-1 drugs, and what this means for the future

Wegovy and Zepbound are commonly prescribed options, depending on individual health needs and goals